Literature DB >> 2239714

Angiographic assessment of the culprit coronary artery lesion before acute myocardial infarction.

W C Little1.   

Abstract

Serial angiographic studies of patients with myocardial infarction and unstable angina suggest that the culprit plaque underlying a thrombus need not have produced severe luminal obstruction before onset of the event. An atherosclerotic coronary artery lesion can, therefore, have 2 important characteristics. First, it may be obstructive. Second, it may be "vulnerable" in that it has the potential to become thrombogenic if exposed to the appropriate triggering stimulus. A lesion need not be obstructive to become thrombogenic, nor do all obstructive lesions have thrombogenic potential. The cause of an infarction may thus be rupture of a nonobstructive plaque leading to occlusive thrombus formation. Because it may be difficult to predict the site of a subsequent occlusion from a coronary angiogram, coronary bypass surgery or angioplasty directed only at discernible stenotic lesions may not be effective for preventing subsequent myocardial infarctions. Appropriate therapy may need to be directed at the entire coronary tree. Such therapy might include cholesterol lowering, beta blockade and aspirin.

Entities:  

Mesh:

Year:  1990        PMID: 2239714     DOI: 10.1016/0002-9149(90)90395-h

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Vulnerable plaque imaging-current techniques.

Authors:  K Chad Hilty; Daniel H Steinberg
Journal:  J Cardiovasc Transl Res       Date:  2009-01-14       Impact factor: 4.132

2.  A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps.

Authors:  Yuliya Vengrenyuk; Stéphane Carlier; Savvas Xanthos; Luis Cardoso; Peter Ganatos; Renu Virmani; Shmuel Einav; Lane Gilchrist; Sheldon Weinbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

Review 3.  Imaging techniques for the vulnerable coronary plaque.

Authors:  F Cademartiri; L La Grutta; A Palumbo; E Maffei; A Aldrovandi; R Malagò; F Alberghina; F Pugliese; G Runza; M Belgrano; M Midiri; M A Cova; G P Krestin
Journal:  Radiol Med       Date:  2007-07-24       Impact factor: 3.469

4.  Magnetic resonance imaging of carotid atherosclerotic plaque in clinically suspected acute transient ischemic attack and acute ischemic stroke.

Authors:  Jaywant P Parmar; Walter J Rogers; John P Mugler; Erol Baskurt; Talissa A Altes; Kiran R Nandalur; George J Stukenborg; C Douglas Phillips; Klaus D Hagspiel; Alan H Matsumoto; Michael D Dake; Christopher M Kramer
Journal:  Circulation       Date:  2010-11-01       Impact factor: 29.690

5.  Management of Acute Ischemic Coronary Syndromes: The Present and Future.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-11       Impact factor: 2.300

6.  Pitavastatin: finding its place in therapy.

Authors:  Leiv Ose
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

7.  Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease.

Authors:  Cheuk-Man Yu; Qing Zhang; Linda Lam; Hong Lin; Shun-Ling Kong; Wilson Chan; Jeffrey Wing-Hong Fung; Kenny K K Cheng; Iris Hiu-Shuen Chan; Stephen Wai-Luen Lee; John E Sanderson; Christopher Wai-Kei Lam
Journal:  Heart       Date:  2007-03-07       Impact factor: 5.994

8.  Appropriateness of diagnostic coronary angiography as a measure of cardiac ischemia testing in non-emergency patients - a retrospective cross-sectional analysis.

Authors:  Corinne Chmiel; Oliver Reich; Andri Signorell; Ryan Tandjung; Thomas Rosemann; Oliver Senn
Journal:  PLoS One       Date:  2015-02-26       Impact factor: 3.240

Review 9.  Cardiovascular molecular imaging of apoptosis.

Authors:  S L Wolters; M F Corsten; C P M Reutelingsperger; J Narula; L Hofstra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.